Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3762

1.

Risk of Pertussis in Relation to Degree of Prematurity in Children Less Than 2 Years of Age.

Riise ØR, Laake I, Vestrheim D, Flem E, Moster D, Riise Bergsaker MA, Storsæter J.

Pediatr Infect Dis J. 2017 May;36(5):e151-e156. doi: 10.1097/INF.0000000000001545.

PMID:
28403056
2.

Enhancement of cytokine-driven NK cell IFN-γ production after vaccination of HCMV infected Africans.

Darboe A, Danso E, Clarke E, Umesi A, Touray E, Wegmuller R, Moore SE, Riley EM, Goodier MR.

Eur J Immunol. 2017 Apr 6. doi: 10.1002/eji.201746974. [Epub ahead of print]

PMID:
28383105
3.

Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.

Kwon HJ, Han SB, Kim BR, Kang KR, Huh DH, Choi GS, Ahn DH, Kang JH.

BMC Infect Dis. 2017 Apr 4;17(1):247. doi: 10.1186/s12879-017-2369-x.

4.

Placental transfer of antibody and its relationship to vaccination in pregnancy.

Calvert A, Jones CE.

Curr Opin Infect Dis. 2017 Jun;30(3):268-273. doi: 10.1097/QCO.0000000000000372.

PMID:
28362650
5.

Live pertussis vaccines: will they protect against carriage and spread of pertussis?

Locht C.

Clin Microbiol Infect. 2016 Dec 1;22 Suppl 5:S96-S102. doi: 10.1016/j.cmi.2016.05.029. Epub 2016 Oct 27. Review.

PMID:
28341014
6.

Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal Immunization.

Eberhardt CS, Blanchard-Rohner G, Lemaître B, Combescure C, Othenin-Girard V, Chilin A, Petre J, Martinez de Tejada B, Siegrist CA.

Clin Infect Dis. 2017 Apr 15;64(8):1129-1132. doi: 10.1093/cid/cix046.

PMID:
28329335
7.

What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Burdin N, Handy LK, Plotkin SA.

Cold Spring Harb Perspect Biol. 2017 Mar 13. pii: a029454. doi: 10.1101/cshperspect.a029454. [Epub ahead of print]

PMID:
28289064
8.

Meta-Analysis of Pulmonary Transcriptomes from Differently Primed Mice Identifies Molecular Signatures to Differentiate Immune Responses following <i>Bordetella pertussis</i> Challenge.

Raeven RH, Pennings JL, van Riet E, Kersten GF, Metz B.

J Immunol Res. 2017;2017:8512847. doi: 10.1155/2017/8512847. Epub 2017 Jan 24.

9.

[Adult immunisation: General points, hot topics and perspectives].

Loubet P, Launay O.

Rev Med Interne. 2017 Feb 14. pii: S0248-8663(17)30029-2. doi: 10.1016/j.revmed.2017.01.007. [Epub ahead of print] French.

PMID:
28214181
10.

GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.

Esquerré M, Momot M, Goubier A, Gonindard C, Leung-Theung-Long S, Misseri Y, Bissery MC.

Vaccine. 2017 Mar 13;35(11):1509-1516. doi: 10.1016/j.vaccine.2017.01.074. Epub 2017 Feb 10.

11.

Low uptake of maternal vaccination in notified pertussis cases aged less than 20 weeks.

Reynolds G, Grant N, Thornley S, Hale M.

N Z Med J. 2017 Jan 27;130(1449):72-74. No abstract available.

PMID:
28178735
12.

The impact of prenatal exposure to parasitic infections and to anthelminthic treatment on antibody responses to routine immunisations given in infancy: Secondary analysis of a randomised controlled trial.

Nash S, Mentzer AJ, Lule SA, Kizito D, Smits G, van der Klis FR, Elliott AM.

PLoS Negl Trop Dis. 2017 Feb 8;11(2):e0005213. doi: 10.1371/journal.pntd.0005213. eCollection 2017 Feb.

13.

Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.

Mipatrini D, Stefanelli P, Severoni S, Rezza G.

Pathog Glob Health. 2017 Mar;111(2):59-68. doi: 10.1080/20477724.2017.1281374. Epub 2017 Feb 6. Review.

PMID:
28165878
14.

Immune response and protective profile elicited by a multi-epitope chimeric protein derived from Leptospira interrogans.

Fernandes LG, Teixeira AF, Filho AF, Souza GO, Vasconcellos SA, Heinemann MB, Romero EC, Nascimento AL.

Int J Infect Dis. 2017 Apr;57:61-69. doi: 10.1016/j.ijid.2017.01.032. Epub 2017 Feb 1.

15.

[Strategies to protect the newborn and infants under 6 months of age against pertussis: Statement of the Advisory Committee for Immunizations of the Chilean Infectious Diseases Society].

Potin M, Fica A, Véliz L, Moreno G, Wilhelm J, Cerda J.

Rev Chilena Infectol. 2016 Oct;33(5):543-546. doi: 10.4067/S0716-10182016000500009. Spanish.

16.

Immune persistence after pertussis vaccination.

Chen Z, He Q.

Hum Vaccin Immunother. 2017 Apr 3;13(4):744-756. doi: 10.1080/21645515.2016.1259780. Epub 2017 Jan 3. Review.

PMID:
28045580
17.

DTaP5-HB-IPV-Hib Vaccine (Vaxelis<sup>®</sup>): A Review of its Use in Primary and Booster Vaccination.

Syed YY.

Paediatr Drugs. 2017 Feb;19(1):69-80. doi: 10.1007/s40272-016-0208-y. Review.

PMID:
28035545
18.

Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3-6years.

Southern J, Waight PA, Andrews N, Miller E.

Vaccine. 2017 Jan 23;35(4):619-625. doi: 10.1016/j.vaccine.2016.12.017. Epub 2016 Dec 23.

PMID:
28017441
19.

Recommended vaccinations for asplenic and hyposplenic adult patients.

Bonanni P, Grazzini M, Niccolai G, Paolini D, Varone O, Bartoloni A, Bartalesi F, Santini MG, Baretti S, Bonito C, Zini P, Mechi MT, Niccolini F, Magistri L, Pulci MB, Boccalini S, Bechini A.

Hum Vaccin Immunother. 2017 Feb;13(2):359-368. doi: 10.1080/21645515.2017.1264797.

20.

Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013.

Godoy P, García-Cenoz M, Toledo D, Carmona G, Caylà JA, Alsedà M, Àlvarez J, Barrabeig I, Camps N, Plans P, Company M, Castilla J, Sala-Farré MR, Muñoz-Almagro C, Rius C, Domínguez À; Transmission of Pertussis in Households Working Group..

Euro Surveill. 2016 Nov 10;21(45). pii: 30393. doi: 10.2807/1560-7917.ES.2016.21.45.30393.

Supplemental Content

Loading ...
Support Center